Jackie R. Bickenbach
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Jackie R. Bickenbach has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
Molly Kulesz-Martin
Department of Dermatology, Oregon Health & Science University, Portland, Oregon, USA
4 shared publicationsKatie L. Grinnell
Department of Anatomy and Cell Biology, The University of Iowa Carver College of Medicine, Iowa City, Iowa 52242, USA
3 shared publicationsSathivel Chinnathambi
Department of Anatomy and Cell Biology, Caver College of Medicine, The University of Iowa, Iowa City, Iowa, USA
3 shared publicationsAnn Tomanek-Chalkley
Department of Anatomy and Cell Biology, Carver College of Medicine, the University of Iowa, Iowa City, Iowa
2 shared publicationsMatthew M. Stern
Department of Anatomy and Cell Biology, Caver College of Medicine, The University of Iowa, Iowa City, Iowa, USA
2 shared publicationsMichael C. Winter
Department of Anatomy and Cell Biology, Carver College of Medicine, the University of Iowa, Iowa City, Iowa
2 shared publications
Latest Publications
- Open Access
- 1 June 2013
- Published by SAGE Publications in BioResearch Open Access
- Vol. 2 (3) , 217-221
Human Skin Keratinocytes Can Be Reprogrammed to Express Neuronal Genes and Proteins After a Single Treatment with Decitabine
Patient-specific cell replacement therapy is fast becoming the future of medicine, requiring safe, effective methods for reprogramming a patient's own cells. Previously, we showed that a single transient transfection with a plasmid encoding Oct4 was sufficient to reprogram human skin keratinocytes (HSKs), and that this transfection resulted in a decrease in global DNA methylation. In more recent work we showed that decreasing global DNA methylation using the U.S. Food and Drug Administration-approved cancer treatment drug decitabine was sufficient to induce expression of endogenous Oct4. Here we report that a single treatment with decitabine, followed by 5 days in a defined neuronal transformation medium, then 7 days in a neuronal maintenance medium is sufficient to convert HSKs into cells that change their morphology substantially, gain expression of neuronal markers, and lose expression of keratinocyte markers. Within 1 week of treatment the cells express mRNA for β3-tubulin and doublecortin, and at the end of 2 weeks express mRNA for NeuN, FOXP2, and NCAM1. Additionally, at the end of this protocol, neurofilament-1, nestin, synapsin, FOXP2, and GluR1 proteins are detectable by immunostaining. Thus, we demonstrate a simple method that begins the process for producing cells for cell replacement therapies without using exogenously introduced DNA.
- 1 June 2013
- Published by SAGE Publications in BioResearch Open Access
- Vol. 2 (3) , 217-221
Open AccessHuman Skin Keratinocytes Can Be Reprogrammed to Express Neuronal Genes and Proteins After a Single Treatment with Decitabine
Patient-specific cell replacement therapy is fast becoming the future of medicine, requiring safe, effective methods for reprogramming a patient's own cells. Previously, we showed that a single transient transfection with a plasmid encoding Oct4 was sufficient to reprogram human skin keratinocytes (HSKs), and that this transfection resulted in a decrease in global DNA methylation. In more recent work we showed that decreasing global DNA methylation using the U.S. Food and Drug Administration-approved cancer treatment drug decitabine was sufficient to induce expression of endogenous Oct4. Here we report that a single treatment with decitabine, followed by 5 days in a defined neuronal transformation medium, then 7 days in a neuronal maintenance medium is sufficient to convert HSKs into cells that change their morphology substantially, gain expression of neuronal markers, and lose expression of keratinocyte markers. Within 1 week of treatment the cells express mRNA for β3-tubulin and doublecortin, and at the end of 2 weeks express mRNA for NeuN, FOXP2, and NCAM1. Additionally, at the end of this protocol, neurofilament-1, nestin, synapsin, FOXP2, and GluR1 proteins are detectable by immunostaining. Thus, we demonstrate a simple method that begins the process for producing cells for cell replacement therapies without using exogenously introduced DNA.
- Open Access
- 1 May 2012
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 132 (5) , 1317-1320
Montagna Symposium 2011: 60th Anniversary—Advances in Science and Medicine Catalyzed by Pioneering Skin Research
- 1 May 2012
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 132 (5) , 1317-1320
Open AccessMontagna Symposium 2011: 60th Anniversary—Advances in Science and Medicine Catalyzed by Pioneering Skin Research
- 1 November 2011
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 131 (11) , 2166-2168
Montagna Symposium 2010: Small Molecules: Skin as the First Line of Defense
- 1 November 2011
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 131 (11) , 2166-2168
Montagna Symposium 2010: Small Molecules: Skin as the First Line of Defense
- Open Access
- 28 October 2010
- Published by Springer Nature in Gene Therapy
- Vol. 18 (3) , 294-303
Transient expression of OCT4 is sufficient to allow human keratinocytes to change their differentiation pathway
In this study, we describe a simple system in which human keratinocytes can be redirected to an alternative differentiation pathway. We transiently transfected freshly isolated human skin keratinocytes with the single transcription factor OCT4. Within 2 days these cells displayed expression of endogenous embryonic genes and showed reduced genomic methylation. More importantly, these cells could be specifically converted into neuronal and contractile mesenchymal cell types. Redirected differentiation was confirmed by expression of neuronal and mesenchymal cell mRNA and protein, and through a functional assay in which the newly differentiated mesenchymal cells contracted collagen gels as efficiently as authentic myofibroblasts. Thus, to generate patient-specific cells for therapeutic purposes, it may not be necessary to completely reprogram somatic cells into induced pluripotent stem cells before altering their differentiation and grafting them into new tissues.
- 28 October 2010
- Published by Springer Nature in Gene Therapy
- Vol. 18 (3) , 294-303
Open AccessTransient expression of OCT4 is sufficient to allow human keratinocytes to change their differentiation pathway
In this study, we describe a simple system in which human keratinocytes can be redirected to an alternative differentiation pathway. We transiently transfected freshly isolated human skin keratinocytes with the single transcription factor OCT4. Within 2 days these cells displayed expression of endogenous embryonic genes and showed reduced genomic methylation. More importantly, these cells could be specifically converted into neuronal and contractile mesenchymal cell types. Redirected differentiation was confirmed by expression of neuronal and mesenchymal cell mRNA and protein, and through a functional assay in which the newly differentiated mesenchymal cells contracted collagen gels as efficiently as authentic myofibroblasts. Thus, to generate patient-specific cells for therapeutic purposes, it may not be necessary to completely reprogram somatic cells into induced pluripotent stem cells before altering their differentiation and grafting them into new tissues.
- 1 May 2010
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 130 (5) , 1199-1201
Montagna Symposium 2009: Genetic–Epigenetic Basis of Skin Diseases
- 1 May 2010
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 130 (5) , 1199-1201
Montagna Symposium 2009: Genetic–Epigenetic Basis of Skin Diseases
- 1 November 2009
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 129 (11) , 2541-2543
Aging Epidermis Is Maintained by Changes in Transit-Amplifying Cell Kinetics, Not Stem Cell Kinetics
- 1 November 2009
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 129 (11) , 2541-2543
Aging Epidermis Is Maintained by Changes in Transit-Amplifying Cell Kinetics, Not Stem Cell Kinetics
- Open Access
- 19 August 2009
- Published by Impact Journals, LLC in Aging
- Vol. 1 (8) , 746-750
Are epidermal stem cells unique with respect to aging?
Epidermal stem cells are a population of somatic stem cells responsible for maintaining and repairing the epidermis of the skin. A malfunctioning epidermal stem cell compartment results in loss of the epidermis and death of the whole organism. Since the epidermis continually renews itself by sloughing a layer of cells every day, it is in a constant state of cellular turnover and requires continual cell replacement for life. Thus, maintaining a pristine epidermal stem cell population is of prime importance, even during aging. Unlike stem cells from internal tissues, epidermal stem cells show little response to aging. They do not appear to decrease in number or functionality with age, and do not show changes in gene expression, developmental responsiveness, or age-associated increases of reactive oxygen species. Thus, epidermal stem cells may be a unique somatic stem cell.
- 19 August 2009
- Published by Impact Journals, LLC in Aging
- Vol. 1 (8) , 746-750
Open AccessAre epidermal stem cells unique with respect to aging?
Epidermal stem cells are a population of somatic stem cells responsible for maintaining and repairing the epidermis of the skin. A malfunctioning epidermal stem cell compartment results in loss of the epidermis and death of the whole organism. Since the epidermis continually renews itself by sloughing a layer of cells every day, it is in a constant state of cellular turnover and requires continual cell replacement for life. Thus, maintaining a pristine epidermal stem cell population is of prime importance, even during aging. Unlike stem cells from internal tissues, epidermal stem cells show little response to aging. They do not appear to decrease in number or functionality with age, and do not show changes in gene expression, developmental responsiveness, or age-associated increases of reactive oxygen species. Thus, epidermal stem cells may be a unique somatic stem cell.
- 1 June 2008
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 128 (6) , 1351-1353
56th Annual Montagna Symposium on the Biology of Skin: Epidermal T-Cell Interactions—Clinicopathological and Basic Mechanisms
- 1 June 2008
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 128 (6) , 1351-1353
56th Annual Montagna Symposium on the Biology of Skin: Epidermal T-Cell Interactions—Clinicopathological and Basic Mechanisms
- Open Access
- 1 June 2008
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 128 (6) , 1386-1396
Cells Isolated from the Epidermis by Hoechst Dye Exclusion, Small Size, and Negative Selection for Hematopoietic Markers Can Generate B Lymphocyte Precursors
- 1 June 2008
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 128 (6) , 1386-1396
Open AccessCells Isolated from the Epidermis by Hoechst Dye Exclusion, Small Size, and Negative Selection for Hematopoietic Markers Can Generate B Lymphocyte Precursors
- 1 May 2007
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 127 (5) , 988-990
Signaling to Structures: Skin Appendages, Development and Diseases — Meeting Report of the 55th Annual Montagna Symposium on the Biology of Skin
- 1 May 2007
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 127 (5) , 988-990
Signaling to Structures: Skin Appendages, Development and Diseases — Meeting Report of the 55th Annual Montagna Symposium on the Biology of Skin